Transitional cell carcinoma: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 15: | Line 15: | ||
{{SI}} | {{SI}} | ||
'''For patient information page click [[{{PAGENAME}} (patient information)|here]]''' | '''For patient information page click [[{{PAGENAME}} (patient information)|here]]''' | ||
{{SCC}} | {{SCC}} | ||
Revision as of 14:13, 1 August 2012
| Transitional cell carcinoma | |
| ICD-O: | 8120-8130 |
|---|---|
For patient information page click here
Steven C. Campbell, M.D., Ph.D.
Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Transitional cell carcinoma is a type of cancer that originates in the kidney, bladder or ureter. It is the most common type of bladder cancer. It arises from the transitional epithelium lining found in these organs.
Patient #1
Patient#2
